Human Longevity vs Noom

Side-by-side comparison of AI visibility scores, market position, and capabilities

Noom leads in AI visibility (86 vs 53)
Human Longevity logo

Human Longevity

ChallengerHealthcare

Precision Health & Genomics

Human Longevity Inc. offers comprehensive executive health programs combining whole-genome sequencing, full-body MRI, 120+ biomarkers, and AI analysis; launched a longevity app in 2026 and added Nobel laureate advisors.

AI VisibilityBeta
Overall Score
C53
Category Rank
#246 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
56
Perplexity
56
Gemini
58

About

Human Longevity, Inc. (HLI) is a biotechnology and precision health company founded in 2013, applying genomics, multimodal diagnostics, and artificial intelligence to extend human healthspan. The company offers what it describes as the most comprehensive executive health assessment available: a single integrated program combining whole-genome sequencing, full-body MRI, more than 120 biomarkers, microbiome analysis, and AI-driven interpretation — all delivered in one visit. Members receive personalized early-detection screening, treatment plans, and continuous health monitoring through HLI''s Executive Health Program and its 100+ Longevity Programs.

Full profile
Noom logo

Noom

GrowthHealthcare

Weight Health Platform

Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.

AI VisibilityBeta
Overall Score
A86
Category Rank
#12 of 596
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
81
Gemini
92

About

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.

Full profile

AI Visibility Head-to-Head

53
Overall Score
86
#246
Category Rank
#12
79
AI Consensus
67
stable
Trend
stable
56
ChatGPT
80
56
Perplexity
81
58
Gemini
92
49
Claude
90
54
Grok
83

Key Details

Category
Precision Health & Genomics
Weight Health Platform
Tier
Challenger
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Noom
Weight Health Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.